Friday, August 21, 2026
21.8 C
Bengaluru

Opportunities for Indian Pharma

[wpfilebase tag=file id=75 tpl=download-button /]

Inside this Issue

1. Medical Rep to Country Head by Bhaskar Chakravorti
Bhaskar Chakravorti – Vice President, Micro Labs, talks about the growth of his career and his love for the country he presently calls ‘home’.

2. “Organizational Alignment Begins with a Common Vocabulary” by Hanno Wolfram
Our Editor Anup Soans sits down for a tête-à-tête with Hanno Wolfram – Owner, Innov8 and Member, MedicinMan Editorial Board.

3. Motivation: The No. 1 Challenge for Frontline Managers by K. Hariram
Motivation is created in teams only when ‘people’ and ‘purpose’ are prioritised.

4. A Pharma Technology Company Deeply Rooted in Experience by Krishna Singh
Krishna Singh spent 15 years in the Pharma Industry, beginning as a Medical Rep, before starting GlobalSpace technologies – a real Pharma field force multiplier.

5. Is Pharma Brand Management Promoting Mediocrity? by Shreenivas S
Simply hiring people because they have MBAs, without ascertaining their domain expertise or competency for the job, is a sure recipe for disaster. .

6. To Survive in the Jungle of Pharma Sales, Think like a Lion? by Chandan Kumar
Simple pointers to survive and thrive in the jungle of pharma sales.

7. Indian Pharma’s Many Challenges by Salil Kallianpur
The Indian Pharma Industry faces a multitude of challenges (and opportunities), some of which are unique to different sets of players, such as domestic Co’s and MNCs.

Hot this week

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Topics

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img